TMCI:NASDAQ
Treace Medical Concepts, Inc
US$ 4.60
arrow_downward
-4.47%(-0.22) Siku 1
8 Sep, 13:57:53 GMT -4 · USD
search
Alama zote
Siku 1
Siku 5
Mwezi 1
Miezi 6
YTD
Mwaka 1
Miaka 5
ISIZIDI
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya TMCI...
Fungua
US$ 4.75
Juu
US$ 4.85
Chini
US$ 4.52
Mtaji wa soko
298.83M
Wastani wa kiasi cha mauzo
elfu 374.33
Kiasi cha mauzo ya hisa
elfu 106.50
Juu kwa wiki 52
US$ 7.63
Chini kwa wiki 52
US$ 1.17
EPS
-US$ 0.93
Beta
1.41
Hisa za wawekezaji
65.04M
Idadi ya wafanyakazi
450
Fungua
US$ 4.75
Juu
US$ 4.85
Chini
US$ 4.52
Mtaji wa soko
298.83M
Wastani wa kiasi cha mauzo
elfu 374.33
Kiasi cha mauzo ya hisa
elfu 106.50
Juu kwa wiki 52
US$ 7.63
Chini kwa wiki 52
US$ 1.17
EPS
-US$ 0.93
Beta
1.41
Hisa za wawekezaji
65.04M
Idadi ya wafanyakazi
450
Wasifu
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Kuhusu Treace Medical Concepts, Inc